Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AxogenMEX:AXGN 44 EV-to-OCF is 2,946.91 as of Aug. 23, 2026. GuruFocus rates MEX:AXGN with a GF Score™ of 44/100 and a GF Value™ of MXN1,610.37 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Axogen ranks worse than 97.29% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Axogen's Enterprise Value is MXN44,342.10 Mil.
Axogen's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was MXN15.05 Mil. Therefore, Axogen's EV-to-OCF for today is 2,946.91.
The historical rank and industry rank for Axogen's EV-to-OCF or its related term are showing as below:
MEX:AXGN'
s EV-to-OCF Range Over the Past 10 Years
Min: -175.79 Med: -31.48 Max: 2053.03
Current: 173.86
During the past 13 years, the highest EV-to-OCF of Axogen was 2053.03. The lowest was -175.79. And the median was -31.48.
MEX:AXGN's EV-to-OCF is ranked worse than 97.29% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 7.73
vs MEX:AXGN: 173.86
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-23), Axogen's stock price is MXN800.66.
Axogen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was MXN0.000. Therefore, Axogen's PE Ratio (TTM) for today is N/A.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Axogen's share price for today is MXN800.66.
Axogen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Axogen EV-to-OCF Related Terms
Axogen EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Axogen's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Axogen's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Axogen EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Axogen's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Axogen's EV-to-OCF falls into.
Axogen's current Enterprise Value is MXN44,342.10 Mil.
Axogen's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN15.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Axogen (MEX:AXGN) has a EV-to-OCF of 2,946.91 as of Aug. 23, 2026. According to the industry distribution chart, Axogen ranks #827 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 97.3%.
Is Axogen's EV-to-OCF too high?
Axogen's current EV-to-OCF is 2,946.91. The Medical Devices & Instruments industry median EV-to-OCF is 7.73. Axogen's value of 2,946.91 is 38023% above this industry median. Based on the distribution chart, Axogen ranks #827 out of 850 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Axogen has a GF Score™ of 44/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's EV-to-OCF compare to ?
According to the Medical Devices & Instruments industry distribution chart, Axogen ranks #827 out of 850 companies for EV-to-OCF. This places Axogen in the lower half of its industry. The industry median EV-to-OCF is 7.73. Axogen's value of 2,946.91 is 38023% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.73, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Axogen's current EV-to-OCF of 2,946.91 is 38023% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Axogen's current EV-to-OCF is 2,946.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (MEX:AXGN) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,610.37, compared to a current price of MXN800.66 — trading 50.3% below its estimated fair value. The current EV-to-OCF is 2,946.91 and 38023% above the Medical Devices & Instruments industry median of 7.73. Axogen's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Axogen (MEX:AXGN), the current EV-to-OCF is 2,946.91 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Axogen (MEX:AXGN) Overvalued in 2026?
Based on GuruFocus' analysis, Axogen stock appears to be undervalued.
The current stock price of MXN800.66 is trading 50.3% below its estimated GF Value™ of MXN1,610.37.
GuruFocus considers Axogen to be Significantly Undervalued.
Key valuation signals for MEX:AXGN:
EV-to-OCF: 2,946.91
GF Value™: MXN1,610.37 vs. price of MXN800.66 (50.3% below fair value)
Industry Position: 38023% above the Medical Devices & Instruments median (#827 of 850)
No single metric tells the full story. See the MEX:AXGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
44GF Score
Get the complete analysis for MEX:AXGN
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AXGN has been successfully added to your 
